Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
12 Consumer Discretionary Stocks Moving In Wednesday’s Intraday Session
Gainers Nerdy (NYSE:NRDY) shares moved upwards by 28.3% to $3.22 during Wednesday’s regular session. Nerdy’s stock is trading…
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell
• Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
National Vision Holdings’s Earnings: A Preview
National Vision Holdings (NASDAQ:EYE) is set to give its latest quarterly earnings report on Wednesday, 2023-03-01. Here’s what…
Benzinga’s Top Ratings Upgrades, Downgrades For January 17, 2023
Upgrades For Casa Systems Inc (NASDAQ:CASA), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform.…
Citigroup Maintains Buy on National Vision Holdings, Raises Price Target to $48
Citigroup analyst Paul Lejuez maintains National Vision Holdings (NASDAQ:EYE) with a Buy and raises the price target from $41 to $48.
Goldman Sachs Maintains Buy on National Vision Holdings, Raises Price Target to $41
Goldman Sachs analyst Kate McShane maintains National Vision Holdings (NASDAQ:EYE) with a Buy and raises the price target from $36 to $41.
Morgan Stanley Maintains Overweight on National Vision Holdings, Raises Price Target to $43
Morgan Stanley analyst Simeon Gutman maintains National Vision Holdings (NASDAQ:EYE) with a Overweight and raises the price target from $40 to $43.